I agree that this site is using cookies. You can find further informations here.
X
Hashiguchi, Yumi
46  results:
Search for persons X
?
1

Validation and development of population pharmacokinetic mo..:

Oda, Kazutaka ; Matsumoto, Kazuaki ; Shoji, Kensuke...
Journal of Infection and Chemotherapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Population Pharmacokinetics and AUC-Guided Dosing of Tobram..:

Hashiguchi, Yumi ; Matsumoto, Naoya ; Oda, Kazutaka..
Clinical Therapeutics.  45 (2023)  5 - p. 400-414.e2 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Performance of Area under the Concentration-Time Curve Esti..:

Oda, Kazutaka ; Hashiguchi, Yumi ; Kimura, Toshimi...
Pharmaceutical Research.  38 (2021)  4 - p. 637-646 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Lowered Risk of Nephrotoxicity through Intervention against..:

Oda, Kazutaka ; Hashiguchi, Yumi ; Katanoda, Tomomi...
Microbiology Spectrum.  9 (2021)  1 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
5

Development and evaluation of a vancomycin dosing nomogram ..:

Oda, Kazutaka ; Katanoda, Tomomi ; Hashiguchi, Yumi...
Journal of Infection and Chemotherapy.  26 (2020)  5 - p. 444-450 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Clinical evaluation of cefotiam in the treatment of bactere..:

Hashiguchi, Yumi ; Oda, Kazutaka ; Katanoda, Tomomi...
Journal of Infection and Chemotherapy.  26 (2020)  11 - p. 1158-1163 , 2020
Link: https://doi.org/10.1016/..
 
?
7

A case of recovery from aphasia following dose reduction of..:

Oda, Kazutaka ; Miyakawa, Toshikazu ; Katanoda, Tomomi...
Journal of Infection and Chemotherapy.  26 (2020)  5 - p. 498-501 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Continuous high-dose infusion of doripenem in a pneumonia p..:

Oda, Kazutaka ; Kamohara, Hidenobu ; Katanoda, Tomomi...
Journal of Pharmaceutical Health Care and Sciences.  5 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
9

Raltegravir blocks the infectivity of red-fluorescent-prote..:

Ogata-Aoki, Hiromi ; Higashi-Kuwata, Nobuyo ; Hattori, Shin-ichiro...
Antiviral Research.  149 (2018)  - p. 78-88 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Role of P-glycoprotein in the efflux of raltegravir from hu..:

Hashiguchi, Yumi ; Hamada, Akinobu ; Shinohara, Takashi...
Biochemical and Biophysical Research Communications.  439 (2013)  2 - p. 221-227 , 2013
Link: https://doi.org/10.1016/..
 
?
11

Lowered Risk of Nephrotoxicity through Intervention against..:

Oda, Kazutaka ; Hashiguchi, Yumi ; Katanoda, Tomomi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552786/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Raltegravir blocks the infectivity of red-fluorescent-prote..:

Ogata-Aoki, Hiromi ; Higashi-Kuwata, Nobuyo ; Hattori, Shin-ichiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057117/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Lowered Risk of Nephrotoxicity through Intervention against..:

Kazutaka Oda ; Yumi Hashiguchi ; Tomomi Katanoda...
https://journals.asm.org/doi/10.1128/Spectrum.00355-21.  , 2021
Link: https://doi.org/10.1128/..
 
?
14

Continuous high-dose infusion of doripenem in a pneumonia p..:

Kazutaka Oda ; Hidenobu Kamohara ; Tomomi Katanoda...
http://link.springer.com/article/10.1186/s40780-019-0144-4.  , 2019
Link: https://doi.org/10.1186/..
 
?
15

CVaR-based optimization of environmental flow via the Marko..:

Yoshioka, Hidekazu ; Tanaka, Tomohiro ; Yoshioka, Yumi..
Optimization and Engineering.  24 (2023)  4 - p. 2935-2972 , 2023
Link: https://doi.org/10.1007/..
 
1-15